Scholar Rock Holding is a biotechnology business based in the US. Scholar Rock Holding shares (SRRK) are listed on the NASDAQ and all prices are listed in US Dollars. Scholar Rock Holding employs 150 staff and has a market cap (total outstanding shares value) of 0.00.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $8.78 |
|---|---|
| 52-week range | $5.94 - $21.17 |
| 50-day moving average | $8.80 |
| 200-day moving average | $13.10 |
| Wall St. target price | $27.86 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-2.22 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $8.78 from 2024-09-04
| 1 week (2024-08-29) | -5.79% |
|---|---|
| 1 month (2024-08-05) | 4.65% |
| 3 months (2024-06-05) | -10.68% |
| 6 months (2024-03-05) | -44.50% |
| 1 year (2023-09-05) | 45.36% |
|---|---|
| 2 years (2022-09-02) | -2.55% |
| 3 years (2021-09-03) | 36.41 |
| 5 years (2019-09-05) | 10.65 |
| Gross profit TTM | $-89,851,000 |
|---|---|
| Return on assets TTM | -51.2% |
| Return on equity TTM | -121.29% |
| Profit margin | 0% |
| Book value | $1.67 |
| Market Capitalization | $744.3 million |
TTM: trailing 12 months
We're not expecting Scholar Rock Holding to pay a dividend over the next 12 months.
Over the last 12 months, Scholar Rock Holding's shares have ranged in value from as little as $5.94 up to $21.17. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Scholar Rock Holding's is 0.855. This would suggest that Scholar Rock Holding's shares are less volatile than average (for this exchange).
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts. .
Use this calculator to quickly see potential outcomes of your options trades.
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
Advanced Micro Devices (AMD), Intel Corporation (INTC) and Qualcomm Inc (QCOM) are top stocks like Nvidia. See our full list here.
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.